Back to search

Article

Effects of Pycnogenol<sup>®</sup>in post-COVID-19 condition (PYCNOVID): A single-center, placebo controlled, quadruple-blind, randomized trial

2025-06-20

Abstract excerpt

<h4>Background</h4> Post-COVID-19 condition (PCC) remains a public health challenge with limited treatment options. <h4>Objective</h4> To evaluate the effects of Pycnogenol ® , a French maritime pine bark extract with anti-inflammatory and antioxidative properties, versus placebo on patient-reported health status in individuals with PCC. <h4>Design</h4> Single-center, placebo-controlled, quadruple-blind, randomize...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
206f7edd-8d8e-54de-90c9-12582ce172bc
DOI
10.1101/2025.06.12.25329489
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of Pycnogenol<sup>®</sup>in post-COVID-19 condition (PYCNOVID): A single-center, placebo controlled, quadruple-blind, randomized trialDOI 10.1101/2025.06.12.25329489
Select a neighboring publication to make it the new centre.